RxDoctor Payments Data

Kara McKendry, PA

Medical · Pittsburgh, PANPI 1093067290

Payments from drug & device makers

$11,264in general payments, 2019–2025

Across 64 payments — averaging $176.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$9K
  • Biogen$580
  • Genentech USA, Inc.$390
  • AbbVie$262
  • Genentech, Inc.$234
  • EMD Serono, Inc.$227
  • plus $600 from 5 others

What the payments were for

  • Consulting fees$8,01971%
  • Speaking & faculty fees$9729%
  • Food & beverage$1,97518%
  • Education$2993%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,264 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$10,844
Medicare patients
55
Services billed
95

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Kesimpta PenOfatumumab15$151,714
AubagioTeriflunomide20$147,133
CopaxoneGlatiramer Acetate11$74,824
Nurtec OdtRimegepant Sulfate13$23,991
MyrbetriqMirabegron19$10,090
Dalfampridine ErDalfampridine43$9,718
HorizantGabapentin Enacarbil11$5,308
Gabapentin122$3,094
Baclofen67$1,612
Modafinil27$930
Carbamazepine ErCarbamazepine12$585
Pregabalin21$562
Oxybutynin Chloride ErOxybutynin Chloride21$402
Tizanidine Hcl13$309
Levetiracetam17$228

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
SanofiAubagio$8,971$147,13320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →